Literature DB >> 8912133

Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.

S J Hwang1, M J Tong, P P Lai, E S Ko, R L Co, D Chien, G Kuo.   

Abstract

In order to evaluate the roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) and their clinical significance in Asian-American and Caucasian patients with hepatocellular carcinoma (HCC) in the USA, 110 HCC patients, seen in a community-based teaching hospital in the Los Angeles area over a 10 year period, were enrolled. Seventy-nine (72%) patients were Asian-American and 31 (28%) were Caucasians. Of the 110 HCC patients, 69 (63%) were positive for serum hepatitis B surface antigen (HBsAg), 26 (24%) were positive for serum antibody to hepatitis C virus (anti-HCV), five (all Asian-Americans) were positive for both markers; 11 (10%) patients had a history of alcoholism. HBsAg was detected in 63 (80%) Asian-American patients, significantly higher than in the six (19%) Caucasian HCC patients (P < 0.01). Anti-HCV was detected in 10 (32%) Caucasian and in 16 (20%) Asian-American HCC patients (P > 0.05). Among Asian-American HCC patients, anti-HCV was more prevalent in those who were HBsAg-negative than in the HBsAg-positive patients (69 vs 8%; P < 0.01). A history of alcoholism was obtained in nine (29%) Caucasian HCC patients, significantly higher than in the two (3%) Asian-American HCC patients (P < 0.05). Comparing HCC patients with positive HBsAg and with anti-HCV, HBsAg-positive HCC patients were younger, Asian-Americans and predominantly male; 38% had a family history of liver disease. In contrast, anti-HCV-positive HCC patients were older by nearly a decade and 46% had a history of blood transfusion. Using a stepwise logistic regression analysis, Asian race and patient age < 50 years were found to be independent predictors for HBsAg-positivity, while a history of blood transfusion was the only predictor for anti-HCV-positivity in HCC patients. There was no significant difference in the rate of cirrhosis, serum levels of alpha-fetoprotein and survival between HBsAg-positive and anti-HCV-positive HCC patients. In conclusion, chronic HBV infection was the major aetiological factor in Asian-American HCC patients, while chronic HCV infection and alcoholism were major aetiological factors in Caucasian HCC patients in the USA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912133

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  24 in total

1.  Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.

Authors:  Linda-L Wong; Whitney-M Limm; Naoky Tsai; Richard Severino
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men.

Authors:  John H Choe; Victoria M Taylor; Yutaka Yasui; Nancy Burke; Tung Nguyen; Elizabeth Acorda; J Carey Jackson
Journal:  J Immigr Minor Health       Date:  2006-07

3.  Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.

Authors:  M J Tong; L P Lai; K Murakami-Mori
Journal:  West J Med       Date:  1997-08

4.  Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.

Authors:  Benjamin Yip; James M Wantuck; Lily H Kim; Robert J Wong; Aijaz Ahmed; Gabriel Garcia; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

5.  Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.

Authors:  Myron J Tong; Hai-En Sun; Carlos Hsien; David S K Lu
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

6.  Factors associated with hepatitis B testing among Vietnamese Americans.

Authors:  Tung T Nguyen; Stephen J McPhee; Susan Stewart; Ginny Gildengorin; Lena Zhang; Ching Wong; Annette E Maxwell; Roshan Bastani; Vicky M Taylor; Moon S Chen
Journal:  J Gen Intern Med       Date:  2010-03-20       Impact factor: 5.128

7.  Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study.

Authors:  Jonathan Chao; Ellen T Chang; Samuel K S So
Journal:  BMC Public Health       Date:  2010-02-25       Impact factor: 3.295

Review 8.  Hepatitis B awareness, knowledge, and screening among Asian Americans.

Authors:  Tung T Nguyen; Vicky Taylor; Moon S Chen; Roshan Bastani; Annette E Maxwell; Stephen J McPhee
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

9.  Symptom management in hepatocellular carcinoma.

Authors:  Virginia Chih-Yi Sun; Linda Sarna
Journal:  Clin J Oncol Nurs       Date:  2008-10       Impact factor: 1.027

10.  Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation.

Authors:  Jessica P Hwang; Manal M Hassan
Journal:  BMC Cancer       Date:  2009-02-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.